Renoprotective effects of coenzyme Q10 supplementation in patients with chronic kidney disease: a protocol for a systematic review
Introduction Coenzyme Q10 (CoQ10) is a fat-soluble vitamin-like quinone. The plasma levels of CoQ10 are reduced in patients with chronic kidney disease (CKD). CoQ10 supplementation can improve mitochondrial function and decrease oxidative stress in these patients. This systematic review will assess...
Saved in:
Main Authors: | Hisashi Noma, Takeshi Hasegawa, Hiroki Nishiwaki, Erika Ota, Taihei Suzuki, Yoshitaka Watanabe, Yoshifusa Abe |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-12-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/12/e084088.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of coenzyme q10 supplementation on metabolic and reproductive outcomes in obese rats
by: Gisela Belén Sarrible, et al.
Published: (2025-02-01) -
Involvement of Coenzyme Q10 in Various Neurodegenerative and Psychiatric Diseases
by: Alireza Ebrahimi, et al.
Published: (2023-01-01) -
Effect of Coenzyme-Q10 on Doxorubicin-Induced Nephrotoxicity in Rats
by: Azza A. K. El-Sheikh, et al.
Published: (2012-01-01) -
Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells
by: Mitchell Titley, et al.
Published: (2021-01-01) -
Hematological effects of coenzyme q10 in streptozotocin-induced diabetic rats
by: Ercan Keskin, et al.